Skip to main content
NCBI home page
Gut logoLink to Gut
. 1979 Oct;20(10):840–847. doi: 10.1136/gut.20.10.840

Vitamin D metabolism in acute and chronic cholestasis

R T Jung, M Davie, P Siklos, T M Chalmers, J O Hunter, D E M Lawson
PMCID: PMC1412708  PMID: 230129

Abstract

To study the effects of acute and chronic cholestasis on vitamin D metabolism we investigated six cases of acute extrahepatic obstructive jaundice and eight cases of primary biliary cirrhosis (PBC) (three supplemented with vitamin D). Plasma 25-hydroxyvitamin D (25OHD) was low in the patients with PBC unsupplemented with vitamin D but normal in obstructive jaundice. None of the patients with PBC showed radiological or histological evidence of osteomalacia. In PBC, dietary intake of vitamin D was low but response to ultra-violet irradiation of the skin was normal even in those with a considerably raised serum bilirubin. Patients with PBC or obstructive jaundice had low levels of 25 hydroxyvitamin D binding protein which correlated with the serum albumin. The half-life of intravenously injected 3H vitamin D3 (3HD3) and the subsequent production of 3H 25OHD were normal in all the patients with obstructive jaundice and in most with PBC. The two patients with PBC who produced less 3H 25OHD than expected were receiving vitamin D supplements. The urinary tritium (3H) excretion after the injection of 3HD3 correlated with the serum bilirubin. After the injection of 3H 25OHD3 the urinary excretion of 3H was minimal and did not correlate with the serum bilirubin, suggesting that the radioactivity appearing in the urine after the 3H vitamin D3 injection was associated with vitamin D metabolites other than 25OHD. Factors contributing to the low plasma 25OHD in primary biliary cirrhosis may be a low dietary intake of vitamin D, inadequate exposure to ultra-violet light, and a tendency to urinary wastage of vitamin D metabolites.

Full text

PDF
840

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ATKINSON M., NORDIN B. E., SHERLOCK S. Malabsorption and bone disease in prolonged obstructive jaundice. Q J Med. 1956 Jul;25(99):299–312. [PubMed] [Google Scholar]
  2. Ajdukiewicz A. B., Agnew J. E., Byers P. D., Wills M. R., Sherlock S. The relief of bone pain in primary biliary cirrhosis with calcium infusions. Gut. 1974 Oct;15(10):788–793. doi: 10.1136/gut.15.10.788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bouillon R., Van Baelen H., Rombauts W., De Moor P. The purification and characterisation of the human-serum binding protein for the 25-hydroxycholecalciferol (transcalciferin). Identity with group-specific component. Eur J Biochem. 1976 Jul 1;66(2):285–291. doi: 10.1111/j.1432-1033.1976.tb10518.x. [DOI] [PubMed] [Google Scholar]
  4. Chalmers T. M., Hunter J. O., Davie M. W., Szaz K. F., Pelc B., Kodicek E. 1-Alpha-hydroxycholecalciferol as a substitute for the kidney hormone 1,25-dihydroxycholecalciferol in chronic renal failure. Lancet. 1973 Sep 29;2(7831):696–699. doi: 10.1016/s0140-6736(73)92536-1. [DOI] [PubMed] [Google Scholar]
  5. Compston J. E., Thompson R. P. Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis. Lancet. 1977 Apr 2;1(8014):721–724. doi: 10.1016/s0140-6736(77)92167-5. [DOI] [PubMed] [Google Scholar]
  6. Daum F., Rosen J. F., Roginsky M., Cohen M. I., Finberg L. 25-Hydroxycholecalciferol inthe management of rickets associated with extrahepatic biliary atresia. J Pediatr. 1976 Jun;88(6):1041–1043. doi: 10.1016/s0022-3476(76)81073-6. [DOI] [PubMed] [Google Scholar]
  7. Edelstein S., Charman M., Lawson D. E., Kodicek E. Competitive protein-binding assay for 25-hydroxycholecalciferol. Clin Sci Mol Med. 1974 Feb;46(2):231–240. doi: 10.1042/cs0460231. [DOI] [PubMed] [Google Scholar]
  8. Glasgow J. F., Thomas P. S. The osteodystrophy of prolonged obstructive liver disease in childhood. Acta Paediatr Scand. 1976 Jan;65(1):57–64. doi: 10.1111/j.1651-2227.1976.tb04408.x. [DOI] [PubMed] [Google Scholar]
  9. Haddad J. G., Jr, Hahn T. J. Natural and synthetic sources of circulating 25-hydroxyvitamin D in man. Nature. 1973 Aug 24;244(5417):515–517. doi: 10.1038/244515a0. [DOI] [PubMed] [Google Scholar]
  10. Haddad J. G., Jr, Walgate J. Radioimmunoassay of the binding protein for vitamin D and its metabolites in human serum: concentrations in normal subjects and patients with disorders of mineral homeostasis. J Clin Invest. 1976 Nov;58(5):1217–1222. doi: 10.1172/JCI108575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jung R. T., Davie M., Hunter J. O., Chalmers T. M., Lawson D. E. Abnormal vitamin D metabolism in cirrhosis. Gut. 1978 Apr;19(4):290–293. doi: 10.1136/gut.19.4.290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kehayoglou A. K., Holdsworth C. D., Agnew J. E., Whelton M. J., Sherlock S. Bone disease and calcium absorption in primary biliary cirrhosis with special reference to vitamin-D therapy. Lancet. 1968 Apr 6;1(7545):715–718. doi: 10.1016/s0140-6736(68)92164-8. [DOI] [PubMed] [Google Scholar]
  13. Krawitt E. L., Grundman M. J., Mawer E. B. Absorption, hydroxylation, and excretion of vitamin D3 in primary biliary cirrhosis. Lancet. 1977 Dec 17;2(8051):1246–1249. doi: 10.1016/s0140-6736(77)92660-5. [DOI] [PubMed] [Google Scholar]
  14. Long R. G., Meinhard E., Skinner R. K., Varghese Z., Wills M. R., Sherlock S. Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease. Gut. 1978 Feb;19(2):85–90. doi: 10.1136/gut.19.2.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Long R. G., Skinner R. K., Wills M. R., Sherlock S. Formation of vitamin D metabolites from 3H- and 14C-radiolabelled vitamin D-3 in chronic liver diseases. Clin Chim Acta. 1978 May 2;85(3):311–317. doi: 10.1016/0009-8981(78)90309-1. [DOI] [PubMed] [Google Scholar]
  16. Long R. G., Skinner R. K., Wills M. R., Sherlock S. Serum-25-hydroxy-vitamin-D in untreated parenchymal and cholestatic liver disease. Lancet. 1976 Sep 25;2(7987):650–652. doi: 10.1016/s0140-6736(76)92463-6. [DOI] [PubMed] [Google Scholar]
  17. Mawer E. B., Reeve A. The use of an isolated perfused liver to study the control of cholecalciferol-25-hydroxylase activity in the rat. Calcif Tissue Res. 1977 May;22 (Suppl):24–28. doi: 10.1007/BF02064035. [DOI] [PubMed] [Google Scholar]
  18. Pittet P. G., Davie M., Lawson D. E. Role of nutrition in the development of osteomalacia in the elderly. Nutr Metab. 1979;23(2):109–116. doi: 10.1159/000176247. [DOI] [PubMed] [Google Scholar]
  19. Poskitt E. M., Cole T. J., Lawson D. E. Diet, sunlight, and 25-hydroxy vitamin D in healthy children and adults. Br Med J. 1979 Jan 27;1(6158):221–223. doi: 10.1136/bmj.1.6158.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Preece M. A., TomlinsonS, Ribot C. A., Pietrek J., Korn H. T., Davies D. M., Ford J. A., Dunnigan M. G., O'Riordan J. L. Studies of vitamin D deficiency in man. Q J Med. 1975 Oct;44(176):575–589. [PubMed] [Google Scholar]
  21. Wagonfeld J. B., Nemchausky B. A., Bolt M., Horst J. V., Boyer J. L., Rosenberg I. H. Comparison of vitamin D and 25-hydroxy-vitamin-D in the therapy of primary biliary cirrhosis. Lancet. 1976 Aug 21;2(7982):391–394. doi: 10.1016/s0140-6736(76)92407-7. [DOI] [PubMed] [Google Scholar]
  22. Woods C. G., Morgan D. B., Paterson C. R., Gossmann H. H. Measurement of osteoid in bone biopsy. J Pathol Bacteriol. 1968 Apr;95(2):441–447. doi: 10.1002/path.1700950214. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES